Cargando…

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Muecksch, Frauke, Weisblum, Yiska, Barnes, Christopher O., Schmidt, Fabian, Schaefer-Babajew, Dennis, Wang, Zijun, C. Lorenzi, Julio C., Flyak, Andrew I., DeLaitsch, Andrew T., Huey-Tubman, Kathryn E., Hou, Shurong, Schiffer, Celia A., Gaebler, Christian, Da Silva, Justin, Poston, Daniel, Finkin, Shlomo, Cho, Alice, Cipolla, Melissa, Oliveira, Thiago Y., Millard, Katrina G., Ramos, Victor, Gazumyan, Anna, Rutkowska, Magdalena, Caskey, Marina, Nussenzweig, Michel C., Bjorkman, Pamela J., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323339/
https://www.ncbi.nlm.nih.gov/pubmed/34331873
http://dx.doi.org/10.1016/j.immuni.2021.07.008
_version_ 1783731223058710528
author Muecksch, Frauke
Weisblum, Yiska
Barnes, Christopher O.
Schmidt, Fabian
Schaefer-Babajew, Dennis
Wang, Zijun
C. Lorenzi, Julio C.
Flyak, Andrew I.
DeLaitsch, Andrew T.
Huey-Tubman, Kathryn E.
Hou, Shurong
Schiffer, Celia A.
Gaebler, Christian
Da Silva, Justin
Poston, Daniel
Finkin, Shlomo
Cho, Alice
Cipolla, Melissa
Oliveira, Thiago Y.
Millard, Katrina G.
Ramos, Victor
Gazumyan, Anna
Rutkowska, Magdalena
Caskey, Marina
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Hatziioannou, Theodora
Bieniasz, Paul D.
author_facet Muecksch, Frauke
Weisblum, Yiska
Barnes, Christopher O.
Schmidt, Fabian
Schaefer-Babajew, Dennis
Wang, Zijun
C. Lorenzi, Julio C.
Flyak, Andrew I.
DeLaitsch, Andrew T.
Huey-Tubman, Kathryn E.
Hou, Shurong
Schiffer, Celia A.
Gaebler, Christian
Da Silva, Justin
Poston, Daniel
Finkin, Shlomo
Cho, Alice
Cipolla, Melissa
Oliveira, Thiago Y.
Millard, Katrina G.
Ramos, Victor
Gazumyan, Anna
Rutkowska, Magdalena
Caskey, Marina
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Hatziioannou, Theodora
Bieniasz, Paul D.
author_sort Muecksch, Frauke
collection PubMed
description Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from 5 individuals shortly after infection and later in convalescence to determine the impact of maturation over months. In addition to increased affinity and neutralization potency, antibody evolution changed the mutational pathways for the acquisition of viral resistance and restricted neutralization escape options. For some antibodies, maturation imposed a requirement for multiple substitutions to enable escape. For certain antibodies, affinity maturation enabled the neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.
format Online
Article
Text
id pubmed-8323339
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-83233392021-07-30 Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Wang, Zijun C. Lorenzi, Julio C. Flyak, Andrew I. DeLaitsch, Andrew T. Huey-Tubman, Kathryn E. Hou, Shurong Schiffer, Celia A. Gaebler, Christian Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. Immunity Article Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from 5 individuals shortly after infection and later in convalescence to determine the impact of maturation over months. In addition to increased affinity and neutralization potency, antibody evolution changed the mutational pathways for the acquisition of viral resistance and restricted neutralization escape options. For some antibodies, maturation imposed a requirement for multiple substitutions to enable escape. For certain antibodies, affinity maturation enabled the neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses. The Authors. Published by Elsevier Inc. 2021-08-10 2021-07-30 /pmc/articles/PMC8323339/ /pubmed/34331873 http://dx.doi.org/10.1016/j.immuni.2021.07.008 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Muecksch, Frauke
Weisblum, Yiska
Barnes, Christopher O.
Schmidt, Fabian
Schaefer-Babajew, Dennis
Wang, Zijun
C. Lorenzi, Julio C.
Flyak, Andrew I.
DeLaitsch, Andrew T.
Huey-Tubman, Kathryn E.
Hou, Shurong
Schiffer, Celia A.
Gaebler, Christian
Da Silva, Justin
Poston, Daniel
Finkin, Shlomo
Cho, Alice
Cipolla, Melissa
Oliveira, Thiago Y.
Millard, Katrina G.
Ramos, Victor
Gazumyan, Anna
Rutkowska, Magdalena
Caskey, Marina
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Hatziioannou, Theodora
Bieniasz, Paul D.
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
title Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
title_full Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
title_fullStr Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
title_full_unstemmed Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
title_short Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
title_sort affinity maturation of sars-cov-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323339/
https://www.ncbi.nlm.nih.gov/pubmed/34331873
http://dx.doi.org/10.1016/j.immuni.2021.07.008
work_keys_str_mv AT mueckschfrauke affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT weisblumyiska affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT barneschristophero affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT schmidtfabian affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT schaeferbabajewdennis affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT wangzijun affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT clorenzijulioc affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT flyakandrewi affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT delaitschandrewt affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT hueytubmankathryne affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT houshurong affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT schifferceliaa affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT gaeblerchristian affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT dasilvajustin affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT postondaniel affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT finkinshlomo affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT choalice affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT cipollamelissa affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT oliveirathiagoy affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT millardkatrinag affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT ramosvictor affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT gazumyananna affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT rutkowskamagdalena affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT caskeymarina affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT nussenzweigmichelc affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT bjorkmanpamelaj affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT hatziioannoutheodora affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations
AT bieniaszpauld affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations